Adriana Olar to Biomarkers, Tumor
This is a "connection" page, showing publications Adriana Olar has written about Biomarkers, Tumor.
Connection Strength
2.181
-
ATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic features. Clin Neuropathol. 2019 Mar/Apr; 38(2):59-73.
Score: 0.478
-
Phosphohistone H3: implications for clinical practice and risk assessment in meningioma. Neuro Oncol. 2015 May; 17(5):631-3.
Score: 0.364
-
Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification. Semin Radiat Oncol. 2015 Jul; 25(3):155-63.
Score: 0.362
-
Using the molecular classification of glioblastoma to inform personalized treatment. J Pathol. 2014 Jan; 232(2):165-77.
Score: 0.335
-
Biomarkers classification and therapeutic decision-making for malignant gliomas. Curr Treat Options Oncol. 2012 Dec; 13(4):417-36.
Score: 0.310
-
Primary intracranial soft tissue sarcomas in children, adolescents, and young adults: single institution experience and review of the literature. J Neurooncol. 2016 Mar; 127(1):155-63.
Score: 0.096
-
Biological correlates of prostate cancer perineural invasion diameter. Hum Pathol. 2014 Jul; 45(7):1365-9.
Score: 0.085
-
Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma. Ann Diagn Pathol. 2012 Aug; 16(4):255-9.
Score: 0.074
-
DNA methylation-based reclassification of olfactory neuroblastoma. Acta Neuropathol. 2018 08; 136(2):255-271.
Score: 0.028
-
Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol. 2016 06; 40(6):847-56.
Score: 0.025
-
TERT Promoter Mutations and Risk of Recurrence in Meningioma. J Natl Cancer Inst. 2016 May; 108(5).
Score: 0.024